Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
November 27, 2018
Patent Application Number
15404979
Date Filed
January 12, 2017
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed herein are compositions and methods for reducing expression of C9ORF72 mRNA and protein in an animal. Such methods are useful to treat, prevent, ameliorate, or slow progression of neurodegenerative diseases in an individual in need thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.